Esther Puyol-Antón

2papers

2 Papers

80.5CVMar 22
Positional Segmentor-Guided Counterfactual Fine-Tuning for Spatially Localized Image Synthesis

Tian Xia, Matthew Sinclair, Andreas Schuh et al.

Counterfactual image generation enables controlled data augmentation, bias mitigation, and disease modeling. However, existing methods guided by external classifiers or regressors are limited to subject-level factors (e.g., age) and fail to produce localized structural changes, often resulting in global artifacts. Pixel-level guidance using segmentation masks has been explored, but requires user-defined counterfactual masks, which are tedious and impractical. Segmentor-guided Counterfactual Fine-Tuning (Seg-CFT) addressed this by using segmentation-derived measurements to supervise structure-specific variables, yet it remains restricted to global interventions. We propose Positional Seg-CFT, which subdivides each structure into regional segments and derives independent measurements per region, enabling spatially localized and anatomically coherent counterfactuals. Experiments on coronary CT angiography show that Pos-Seg-CFT generates realistic, region-specific modifications, providing finer spatial control for modeling disease progression.

32.7CVMar 25
Confidence Matters: Uncertainty Quantification and Precision Assessment of Deep Learning-based CMR Biomarker Estimates Using Scan-rescan Data

Dewmini Hasara Wickremasinghe, Michelle Gibogwe, Andrew Bell et al.

The performance of deep learning (DL) methods for the analysis of cine cardiovascular magnetic resonance (CMR) is typically assessed in terms of accuracy, overlooking precision. In this work, uncertainty estimation techniques, namely deep ensemble, test-time augmentation, and Monte Carlo dropout, are applied to a state-of-the-art DL pipeline for cardiac functional biomarker estimation, and new distribution-based metrics are proposed for the assessment of biomarker precision. The model achieved high accuracy (average Dice 87%) and point estimate precision on two external validation scan-rescan CMR datasets. However, distribution-based metrics showed that the overlap between scan/rescan confidence intervals was >50% in less than 45% of the cases. Statistical similarity tests between scan and rescan biomarkers also resulted in significant differences for over 65% of the cases. We conclude that, while point estimate metrics might suggest good performance, distributional analyses reveal lower precision, highlighting the need to use more representative metrics to assess scan-rescan agreement.